System and method for detection of HIV tropism variants
Assignee454 Life Sciences Corporation
InventorsBirgitte Binderup Simen, Elizabeth Patricia St. John
Life of this patent
Estimating the term…
Loading patent…
Assignee454 Life Sciences Corporation
InventorsBirgitte Binderup Simen, Elizabeth Patricia St. John
Estimating the term…
An embodiment of a method for detecting low frequency occurrence of one or more HIV sequence variants associated with drug resistance is described that comprises the steps of: generating cDNA species from each RNA molecule in an HIV sample population; amplifying at least one first amplicon from the cDNA species, wherein each first amplicon comprises a plurality of amplified copies and is amplified with a pair of nucleic acid primers that define a locus of the first amplicon; clonally amplifying the amplified copies of the first amplicons to produce a plurality of second amplicons wherein a plurality of the second amplicons comprise an immobilized population of substantially identical copies from one of the amplified copies of first amplicons; determining a nucleic acid sequence composition of the substantially identical copies from at least 100 of the immobilized populations in parallel on a single substrate; and detecting one or more sequence variants that occur at a frequency of 5% or less in the nucleic acid sequence composition of the at least 100 immobilized populations; and correlating the detected sequence variants with variation associated with HIV tropism.
A method for detecting low frequency occurrence of one or more HIV sequence variants associated with drug resistance comprising the steps of:
Dependencies are inferred from the claim text.